The Researcher OG

The Researcher OG Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from The Researcher OG, Alternative & holistic health service, Santa Barbara, CA.
(5)

Mike Robinson, Researcher OG
Ask for a Free ECS Consult

Creator of Researcher®️ Genevieve's Dream™️ Nano Terps®️ Thermonoids®️ GENEVEX®️ Plant Chat®️ PREVENT®️ Get Balanced®️ NANO®️ Jane®️ & more

CEO Nanobles/Global Cannabinoid Research Center GCRC

The smart move is to stay balanced before the crash. Heavy THC use can push the ECS, our Master Regulator, into adaptati...
04/28/2026

The smart move is to stay balanced before the crash. Heavy THC use can push the ECS, our Master Regulator, into adaptation mode, where CB1 signaling gets dulled and the same dose starts feeling weaker. That’s when many consumers think they need more THC, but often the system is asking for support, not another hammer.

That’s where ECS Balance Control comes in. Use ingested CBGA:CBDA combinations, bring in minors like CBG, CBC, CBDV, CBGa, CBN, and support the body with nutrition, hydration, rest, and terpene-rich plant strategies. The goal is to keep the ECS responsive instead of forcing it into a hard reset.

A T-break is what happens when the balance conversation was ignored - nobody needs one unless they truly are addicted to Cannabis and refuse to balance the system.

So stay ahead of it. Support the receptors. Feed the system. Use the plant with intelligence, not just intensity.

That’s not quitting THC.

That’s learning how to keep it working. -Mike Robinson, The Researcher OG

CBC doesn’t get spotlighted, but it sits in the plant like a mechanic with a toolbox. Everybody talks THC, CBG, and CBD,...
04/28/2026

CBC doesn’t get spotlighted, but it sits in the plant like a mechanic with a toolbox. Everybody talks THC, CBG, and CBD, then CBC walks in like, “Cool story, let’s talk inflammation, pain, mood, skin, nerves, and balance.”

CBC is non-intoxicating, so it’s not here to take your steering wheel. It’s being studied for how it may support the ECS, our Master Regulator, through pathways tied to inflammation, discomfort, mood tone, and cell protection.

What makes CBC interesting is that it doesn’t need to act like THC to matter. It seems to work through different signaling routes, including TRP channels and possible support for the body’s own endocannabinoid tone.
That’s the part I love.

CBC isn’t trying to be famous. It’s not the loud cannabinoid at the party. It’s more like the one in the kitchen actually fixing the problem while everyone else is arguing about potency.The plant has range, and CBC is proof.
-Mike Robinson -The Researcher OG

The Researcher OG looks at acidic cannabinoids as part of a prevention-minded approach to health, from immune stress to ...
04/28/2026

The Researcher OG looks at acidic cannabinoids as part of a prevention-minded approach to health, from immune stress to viral pressure, cancer biology, inflammation, and the everyday breakdown that happens when the body stays out of balance too long.

I don’t call them magic. I call them upstream tools.
CBGA, CBDA, THCA, and other acidic cannabinoids are being studied because they interact with biology before the body falls apart - signaling, inflammation, cellular stress, immune tone, and the ECS, our Master Regulator.

That’s where prevention starts. Not after the alarm is screaming, but while the system is still trying to keep the house standing.

That’s why I use acidic cannabinoids the way I do. They aren’t just “raw cannabinoids.” They’re plant-derived support compounds with serious potential for helping the body defend, regulate, and rebalance.

THC gets the headlines. Acidic cannabinoids may be part of the foundation.

The plant had a prevention story the whole time - most just kept trying to smoke the evidence.
-Mike Robinson, The Researcher OG

CBDV is an all star, a cannabinoid many have yet to learn about. It’s non-intoxicating, close to CBD, and shows up natur...
04/28/2026

CBDV is an all star, a cannabinoid many have yet to learn about. It’s non-intoxicating, close to CBD, and shows up naturally in cannabis and h**p, but it comes from the Varin family meaning CBGVa is the precursor.

CBDV is being studied for how it may influence brain signaling, excitation balance, seizure activity, autism-related pathways, nausea, inflammation, and muscle control.

For the ECS, our Master Regulator, CBDV is interesting because it doesn’t seem to work by simply pushing CB1 like THC. Research points more toward modulation - calming overactive signaling, influencing ion channels, and helping the body’s control system communicate with less noise.

That’s why CBDV matters to me, because it helps bring the volume down when the system is firing too hard, it quiets that noise.

CBDV is still early science to many, but it’s one of those cannabinoids that reminds us the plant has more tools than our lives with THC allowed us to learn about.

I dig CBDV, it's perfect for dogs. -Mike Robinson, The Researcher OG

Hormone health runs on timing, feedback, and balance. Thyroid output, stress response, fertility, glucose control, appet...
04/27/2026

Hormone health runs on timing, feedback, and balance. Thyroid output, stress response, fertility, glucose control, appetite, lipids, bone turnover, and metabolism all depend on clean signaling. That’s where cannabinoids and the ECS, our Master Regulator, become part of a bigger health conversation.

Cannabinoids interact with endocannabinoids, CB1, CB2, enzymes, and receptor systems that help regulate communication between the brain, glands, organs, fat tissue, bone, and reproductive system. That means THC, CBD, and other cannabinoids aren’t just affecting mood or pain - they’re touching biological pathways tied to energy, stress, fertility, metabolism, and recovery.

The positive side is the control system itself. The ECS helps the body adjust, respond, and return toward balance when signals drift. This review connects cannabinoids with endocrine pathways involving the thyroid, adrenals, pancreas, ovaries, te**es, bone, and metabolic tissues.

That’s powerful because hormone health isn’t isolated. When inflammation, stress, sleep disruption, glucose swings, or reproductive changes show up, the body needs coordination. Cannabinoids may help influence that coordination through ECS signaling, but the details matter - dose, timing, frequency, age, s*x, and baseline health all shape the response.

The takeaway is simple - cannabinoids are not side biology. They’re part of a regulatory system tied to hormone balance, metabolic health, stress control, and whole-body communication.

-Mike Robinson, Cannabis Patient and Researcher
Study Title: “The effects of cannabis and cannabinoids on the endocrine system” (2021)
Study: https://link.springer.com/article/10.1007/s11154-021-09682-w

Down syndrome and Alzheimer’s risk are tied together by biology, not bad luck. When chromosome 21 is tripled, the brain ...
04/27/2026

Down syndrome and Alzheimer’s risk are tied together by biology, not bad luck. When chromosome 21 is tripled, the brain faces earlier-onset aging, greater inflammatory stress, and greater strain on memory circuits. That’s where the ECS, our Master Regulator, becomes part of the conversation.

A 2025 study found dysregulated CB1 receptor activity in Down syndrome brain tissue and in the Ts65Dn mouse model. CB1 is one of the main receptor switches in the ECS, helping regulate memory signaling, synaptic activity, inflammatory tone, and how neurons respond when the brain is under pressure.

Researchers tested long-term modulation of CB1 receptors with rimonabant, a CB1 receptor antagonist. In the mouse model, treatment improved memory performance and shifted inflammatory markers in a better direction. Microglia, the brain’s immune cleanup crew, also showed changes tied to reduced neuroinflammatory stress.

That matters because Alzheimer’s doesn’t begin as one clean failure. It builds through immune activation, breakdown of the memory circuit, synaptic stress, and inflammation that keeps pushing the brain out of balance. This research doesn’t say the disease was reversed. It shows that targeting a dysregulated ECS signal may help protect function, reduce inflammatory pressure, and support better neurological outcomes.

For families facing Down syndrome, early cognitive decline, or Alzheimer’s risk, this is a serious signal - the ECS belongs in the brain-health conversation.

-Mike Robinson, Cannabis Patient and Researcher
Study Title: “Targeting dysregulated CB1 receptors in a Down syndrome mouse model improves neurological outcomes” (2025)
Study: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.70874

Vázquez-Oliver A, Pérez-García S, Romero-Pérez R, et al. Alzheimer’s & Dementia. 2025. DOI: 10.1002/alz.70874

04/27/2026

Our ECS is what modulates fear response, but with a small percentage of people it’s already Self modulated in a very unique way. I fit into that percentage of people, and I also had a stroke, so it disrupted a lot of different systems. I’m always talking about ECS Balance, look forward to some more videos we can learn how to balance lifestyle that also helps us along with acidic cannabinoids and more - there’s so much good nature can do. -Mike Robinson

Gut trouble isn’t only cramps, bathroom timing, or food choices. It can be a breakdown in motion, barrier defense, immun...
04/27/2026

Gut trouble isn’t only cramps, bathroom timing, or food choices. It can be a breakdown in motion, barrier defense, immune control, pain signaling, and the ECS, our Master Regulator, trying to steady the mess while the gut keeps sending distress signals.

Cannabinoids matter because the gut is wired with CB1, CB2, TRPV1, endocannabinoids, immune cells, nerves, muscle, and epithelial barriers. When that network gets noisy, motility can speed up or slow down, the barrier can leak, inflammation can rise, and pain can become a part of daily life.

Current research pulls together what many patients feel, but science keeps mapping - cannabinoids don’t act in one lane. THC, CBD, endocannabinoids, and receptor-targeted compounds can influence peristalsis, muscle contraction, permeability, inflammation, and gut-brain communication.

That doesn’t mean every cannabinoid fits every gut problem. It means the ECS is a control system, and the gut responds differently by receptor activity, dose, disease state, and baseline balance.

For Crohn’s disease, ulcerative colitis, IBS, and chronic gut disorders, that matters. The goal isn’t to numb the gut into silence. The goal is to reduce inflammatory pressure, protect the barrier, calm pain pathways, and restore rhythm where control was lost.

-Mike Robinson, Cannabis Patient and Researcher
Study Title: “Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases” (2024)
Study: https://www.mdpi.com/1422-0067/25/12/6682

04/26/2026

The morning rituals of the OG should be shared for all, I get up and start my day with metabolic cannabinoids looking to upregulate my system that's been downregulated in sleep all night. I go out and walk as the sun comes up, or as early as I can, and burn off cortisol. Try using Kief Capsules, they're so easy to make with MC Sticky Kief!

Gynecological cancer doesn’t follow a single clear pathway. It can involve hormone signaling, immune pressure, inflammat...
04/24/2026

Gynecological cancer doesn’t follow a single clear pathway. It can involve hormone signaling, immune pressure, inflammation, cell division, apoptosis failure, metabolic disruption, and altered receptor activity across reproductive tissue. When those control systems slip, cancer gains room to grow.

In “(Endo)Cannabinoids and Gynecological Cancers” (2021), researchers reviewed how the ECS, our Master Regulator, may be involved in cancers of the female reproductive tract, including ovarian, cervical, and endometrial cancers. The review states that the ECS includes endocannabinoids, receptors, and enzymes that regulate synthesis and degradation, and that this system has been recognized as a factor in gynecological cancer pathogenesis and progression.

That’s where the conversation gets serious. AEA, 2-AG, OEA, PEA, CB1, CB2, TRPV1, FAAH, NAPE-PLD, and other ECS-related targets aren’t side characters here. They sit within the biology of reproductive tissue, where cell division, differentiation, apoptosis, inflammation, and hormone-linked signaling determine whether tissue remains controlled or begins breaking the rules.

The review notes that AEA and CBD reduced viability in endometrial cancer cell lines at higher tested concentrations, with increases in reactive oxygen species and caspase-3/-7 activity, markers tied to apoptosis. It also discusses AEA-driven cervical cancer cell apoptosis via TRPV1 activation and CBD-mediated concentration-dependent reduction in cancer cell invasiveness.

The authors also make it clear that gynecological cancer research is still limited, endogenous and exogenous cannabinoids don’t behave the same, and in vitro results don’t automatically translate into living patients. That’s not weakness - that’s honest science. But the signal is there. The ECS may help explain part of the cancer terrain, and targeting it could open new diagnostic and therapeutic paths for female reproductive cancers.

-Mike Robinson, The Researcher OG

Study: https://www.mdpi.com/2072-6694/13/1/37

Skin cancer gets dangerous when abnormal cells stop listening to the body’s control signals. They keep dividing, invade ...
04/24/2026

Skin cancer gets dangerous when abnormal cells stop listening to the body’s control signals. They keep dividing, invade nearby tissue, build new blood supply, and look for escape routes into metastasis. That’s not a surface problem - that’s cellular rebellion with a survival plan.

In “Impact of Cannabinoid Compounds on Skin Cancer” (2022), researchers reviewed how cannabinoids may affect melanoma and squamous cell carcinoma through the ECS, our Master Regulator. The review focused on anticarcinogenic mechanisms, including inhibition of tumor growth, proliferation, invasion, and angiogenesis, as well as induction of apoptosis and autophagy.

That’s the part that hits. Cancer survives by avoiding death signals and feeding its own expansion. Cannabinoids and endocannabinoid-related compounds have been studied because they may interrupt several of those pathways simultaneously. In melanoma models, cannabinoid activity has been linked to reduced growth, proliferation, and metastasis, decreased vascular growth, and changes in cell-cycle control. Some findings also show CBD reducing melanoma tumor size in mice, while CBD-treated animals had better quality of life and physical performance than controls, though cisplatin produced the longest survival in that comparison.

The review also gets into the deeper machinery. AEA, PEA, 2-AG, FAAH inhibition, MAGL regulation, CB1, CB2, lipid rafts, GPR55, COX-2 metabolism, ROS, endoplasmic reticulum stress, and caspase activation all show up in the skin cancer discussion. That’s not fluff. That’s the cellular chessboard.

The clean takeaway is simple: cannabinoids aren’t being studied in skin cancer just for comfort care. They’re being studied because the ECS touches survival signaling, tumor growth, vascularization, invasion, metastasis, and programmed cell death. Human trials still need to catch up, but the biology is already too loud to ignore.

-Mike Robinson, The Researcher OG

Study: https://www.mdpi.com/2072-6694/14/7/1769

Skin inflammation isn’t surface-level irritation. It’s immune traffic, cytokine noise, barrier disruption, nerve signali...
04/23/2026

Skin inflammation isn’t surface-level irritation. It’s immune traffic, cytokine noise, barrier disruption, nerve signaling, pain, itching, swelling, and sometimes the kind of chronic inflammatory pressure that can help disease dig in deeper. The skin is alive with ECS activity, and that matters.

In “Cannabinoids in the Pathophysiology of Skin Inflammation” (2020), researchers reviewed how phyto-, endo-, and synthetic cannabinoids interact with inflammatory skin disease, cannabinoid receptors, TRP channels, PPAR pathways, immune mediators, and skin cancer biology. The review explains that normal skin expresses CB1 and CB2 receptors in keratinocytes, hair follicles, sebaceous glands, melanocytes, fibroblasts, nerve fibers, and adipocytes.

That’s not a small detail. When the ECS, our Master Regulator, is active across skin structure, immune defense, sensory input, barrier function, and cellular survival, cannabinoid research becomes more than a topical trend. It becomes a skin-system conversation.

The review notes that cannabinoids may influence cutaneous inflammation through receptor-dependent and receptor-independent mechanisms, including CB1, CB2, TRP channels, GPR targets, PPAR signaling, FAAH, MAGL, AEA, and 2-AG. It also highlights that inflammatory skin disorders can involve chronic cytokine activation, immune overreaction, pain, itching, fibrosis, and a burden on quality of life.

Here’s the OG point - inflamed skin isn’t just “angry skin.” It’s a local immune and nervous-system storm. Cannabinoids are being studied because they may help quiet inflammatory signaling, support barrier function, influence pain and itch pathways, and possibly affect the inflammatory environment associated with skin cancer biology. The research is still calling for stronger controlled human studies, but the mechanism is already speaking clearly.

-Mike Robinson, The Researcher OG

Study: https://www.mdpi.com/1420-3049/25/3/652

Address

Santa Barbara, CA

Opening Hours

Monday 10am - 6pm
Tuesday 7am - 5pm
Wednesday 7am - 5pm
Thursday 2pm - 10pm
Friday 2pm - 10pm
Saturday 10am - 5pm
Sunday 6pm - 10pm

Website

https://GlobalCannabinoidRC.com/, https://GenevievesDream.com/

Alerts

Be the first to know and let us send you an email when The Researcher OG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category